Accelerating Cancer Therapeutics (ACT)

Cancer therapeutic development accelerator program with the goal of advancing cancer therapies from the lab to the clinic; annual TRx pilot award and boot camp are designed to provide resources to develop a commercially relevant targeted product profile and meet targeted 12-month milestones. 

Sponsoring Entities: Herbert Irving Comprehensive Cancer Center, CUMC

Website: http://cancer.columbia.edu/events/2017-12-04-220000/accelerating-cancer-therapeutics-pilot-award

Contact: Emer Smyth, es3551@cumc.columbia.edu